China Medical Imaging Market Report: Market Size & Forecast 2026

China's medical imaging market covers a broad spectrum of diagnostic imaging modalities deployed across public hospitals, private facilities, and specialized imaging centers throughout the country. The market spans the full value chain from equipment manufacturing and distribution to installation, maintenance, and software analytics services. With a substantial installed base of imaging systems and ongoing hospital modernization programs, China represents the largest medical device market in the Asia Pacific region.

• •The market is segmented by modality into X-ray, ultrasound, CT, MRI, and nuclear medicine equipment
• •Hospitals account for the dominant share of end-use demand, while diagnostic imaging centers are expanding rapidly
• •Market value is measured across equipment sales, after-sales services, and software solutions

China's aging population and the rising burden of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders are fueling demand for advanced diagnostic imaging. The government's Healthy China 2030 initiative and tiered healthcare reforms are expanding imaging access beyond major metropolitan areas into tier 3 and 4 cities.

• •Demographic shift toward an older population increases need for early disease detection and screening
• •Healthcare infrastructure expansion in underserved regions drives equipment procurement
• •Growing prevalence of lifestyle-related chronic diseases supports long-term demand growth

CT and MRI systems represent the highest-value segments, while ultrasound and X-ray equipment account for the largest unit volumes due to their broader clinical applications and lower cost points. Eastern coastal provinces including Guangdong, Jiangsu, and Shanghai lead in market adoption, though western and central regions are experiencing faster relative growth as healthcare networks expand.

• •Multislice CT and high-field MRI are the fastest-growing modality segments
• •Public hospitals dominate spending, but private diagnostic chains are gaining share in tier 2 cities
• •Regional disparities persist, with eastern regions holding higher imaging density per capita

What are the recent trends and outlook?

Artificial intelligence-powered image analysis, portable and point-of-care ultrasound devices, and integrated digital imaging platforms are reshaping product development and clinical workflows. Through 2030, the market is expected to sustain steady growth as hospitals upgrade legacy systems and adopt AI-assisted diagnostic tools. Continued government support for domestic innovation and local supply chain development will influence competitive positioning and pricing trends.

• •AI-enabled image interpretation and workflow automation are becoming standard features in new equipment tenders
• •Local manufacturing and domestic content requirements are accelerating Chinese companies' expansion into higher-end segments
• •The market trajectory remains positive through 2030, with sustained investment in healthcare infrastructure underpinning long-term demand